{"entity":{"type":"insider","cik":"0001821266","url":"/insider/0001821266","json_url":"/insider/0001821266.json","name":"Lappe Family Trust","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":5,"first":"2022-10-18","last":"2023-03-01","span_basis":"filed_date"},"name_variants":[{"name":"Lappe Family Trust","source":"filing","n_filings":5,"first_seen":"2022-10-18","last_seen":"2023-03-01"}],"transactions":[{"id":8717291,"accession":"0001739614-23-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-23-000014","line_url":"/filing/0001739614-23-000014#line-1","is_derivative":false,"issuer_cik":"0001366074","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366074","owner_cik":null,"owner_name":"Lappe Mark; Lappe Family Trust","owner_display_name":"Lappe Mark","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60.0,"shares_display":"60","price_per_share":25.0208,"price_display":"25.02","price_state":"stated","total_value":1501.248,"total_display":"1,501.25","total_whole":"1,501","shares_owned_after":2486192.0,"shares_owned_after_display":"2,486,192","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-01","scope":"insider"},{"id":8617962,"accession":"0001739614-23-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001739614-23-000010","line_url":"/filing/0001739614-23-000010","is_derivative":false,"issuer_cik":"0001366074","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366074","owner_cik":null,"owner_name":"Lappe Mark; Lappe Family Trust","owner_display_name":"Lappe Mark","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4335.0,"shares_display":"4,335","price_per_share":25.715852387543254,"price_display":"25.72","price_state":"stated","total_value":111478.2201,"total_display":"111,478.22","total_whole":"111,478","shares_owned_after":2486315.0,"shares_owned_after_display":"2,486,315","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-24","scope":"insider","n_lines":2},{"id":8617958,"accession":"0001739614-23-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-23-000010","line_url":"/filing/0001739614-23-000010#line-1","is_derivative":false,"issuer_cik":"0001366074","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366074","owner_cik":null,"owner_name":"Lappe Mark; Lappe Family Trust","owner_display_name":"Lappe Mark","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21665.0,"shares_display":"21,665","price_per_share":25.3572,"price_display":"25.36","price_state":"stated","total_value":549363.738,"total_display":"549,363.74","total_whole":"549,364","shares_owned_after":2490587.0,"shares_owned_after_display":"2,490,587","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-24","scope":"insider"},{"id":6363515,"accession":"0001739614-22-000130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-22-000130","line_url":"/filing/0001739614-22-000130","is_derivative":false,"issuer_cik":"0001366074","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366074","owner_cik":null,"owner_name":"Lappe Family Trust; Lappe Mark","owner_display_name":"Lappe Family Trust","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":25.5555138,"price_display":"25.56","price_state":"stated","total_value":664443.3588,"total_display":"664,443.36","total_whole":"664,443","shares_owned_after":2513006.0,"shares_owned_after_display":"2,513,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-20","scope":"insider","n_lines":2},{"id":6836456,"accession":"0001739614-22-000124","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001739614-22-000124","line_url":"/filing/0001739614-22-000124","is_derivative":false,"issuer_cik":"0001366074","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366074","owner_cik":null,"owner_name":"Lappe Family Trust; Lappe Mark","owner_display_name":"Lappe Family Trust","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":27.88114535,"price_display":"27.88","price_state":"stated","total_value":724909.7791,"total_display":"724,909.78","total_whole":"724,910","shares_owned_after":2557293.0,"shares_owned_after_display":"2,557,293","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-18","scope":"insider","n_lines":7},{"id":6402809,"accession":"0001739614-22-000107","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001739614-22-000107","line_url":"/filing/0001739614-22-000107","is_derivative":false,"issuer_cik":"0001366074","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366074","owner_cik":null,"owner_name":"Lappe Family Trust; Lappe Mark","owner_display_name":"Lappe Family Trust","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":29.593970103846154,"price_display":"29.59","price_state":"stated","total_value":769443.2227,"total_display":"769,443.22","total_whole":"769,443","shares_owned_after":2567265.0,"shares_owned_after_display":"2,567,265","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-10-18","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001739614","name":"Inhibrx, Inc.","url":"/issuer/0001739614","role":"Other","n_filings":5,"first_seen":"2022-10-18","last_seen":"2023-03-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001821266","retrieved_at":"2026-08-26T07:20:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}